• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Opexa Therapeutics Inc

+ Add to Watchlist

OPXA:US

1.1100 USD 0.1601 12.61%

As of 20:10:00 ET on 09/16/2014.

Snapshot for Opexa Therapeutics Inc (OPXA)

Open: 1.1400 Day's Range: 1.0800 - 1.2300 Volume: 1,596,350
Previous Close: 1.2701 52wk Range: 1.0800 - 2.5600 1-Yr Rtn: -35.47%

Stock Chart for OPXA

No chart data available.
  • OPXA:US 1.1100
  • 1D
  • 1M
  • 1Y
1.2701
Interactive OPXA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OPXA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.8300
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 30.93
Shares Outstanding (M) 27.86
30 Day Average Volume 201,169
Price/Book (mrq) 2.2655
Price/Sale (ttm) 15.3454
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OPXA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OPXA

Opexa Therapeutics, Inc. is biotechnology company. The company develops cellular therapies for the treatment of multiple sclerosis, rheumatoid arthritis, pancreatic, and cardiac conditions. Opexa holds a worldwide license for an autologous T cell vaccine for rheumatoid arthritis.

Neil K WarmaPresident/CEOKarthik RadhakrishnanChief Financial Officer
Donna R RillChief Development Officer
More Company Profile & Key Executives for OPXA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil